If you want to speculate in the stock market, you can see the research report of Jin Kirin analysts.CryptogamesonmobileAuthorityCryptogamesonmobileProfessional, timely, comprehensive, to help you tap the potential theme opportunities!
On the evening of May 13, 2023, Diri Medical announced that the company's profit distribution plan for 2023 had been examined and approved at the 2023 annual general meeting held on May 10, 2024, based on the company's existing total share capital of 274565911 shares. distribute 5 RMB cash to all shareholders for every 10 shares. The registration date of this equity distribution is May 20, 2024, and the de-dividend date is May 21, 2024.
It is understood that Dirui Medical has paid cash dividends to all shareholders for many years in a row. Cash dividends of RMB 4 per 10 shares will be distributed to all shareholders for three consecutive years from 2020 to 2022.Cryptogamesonmobile.9 yuan, 3Cryptogamesonmobile.8 yuan, 4.8 yuan, based on the net profit of Dirui Medical which belongs to the shareholders of the parent company in the past three years, the cash dividend ratio is about 50%.
Since the release of the new "National Nine articles", listed companies have responded positively to the requirements of cash dividends, using practical actions to feed the market and repay the social responsibility of shareholders, enhance the sense of achievement of investors, especially minority shareholders, and protect the legitimate rights and interests of investors. Dirui Medical has practiced a high proportion of cash dividends for many years to promote the high-quality development of the company.
It is reported that according to the Shenyin Wanguo industry classification, among the 38 listed companies in the in vitro diagnosis plate, Dirui Medical Cash dividend ratio ranked seventh in 2023. Among the 49 listed companies in Jilin area, the total cumulative dividend in 2023 ranks first among gem and Science and Technology Innovation Board.
Diri Medical said that the company attaches great importance to investor returns and increases investors' sense of achievement. In the future, we will continue to maintain steady performance growth, enhance investor confidence and safeguard the interests of all shareholders. On the basis of meeting the daily business needs, adhere to a high proportion of cash dividends to give back to the majority of investors.
According to public data, Dirui Medical achieved operating income of 663 million yuan in the first quarter of 2024, an increase of 99.60 percent over the same period last year. The net profit belonging to shareholders of listed companies was 122 million yuan, up 56.73 percent over the same period last year. Net profit belonging to shareholders of listed companies after deducting non-recurring profits and losses increased by 55.53 percent. The long-term investor value of Diri Medical deserves continuous attention from the capital market.